Lipocine (LPCN) Receives a Buy from H.C. Wainwright

Tip Ranks
2025.11.13 11:37
portai
I'm PortAI, I can summarize articles.

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Lipocine with a price target of $7.00. Chen, who covers the Healthcare sector, has an average return of -4.3% and a 41.32% success rate on recommended stocks. Lipocine has an analyst consensus of Moderate Buy with a price target consensus of $6.88.

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Lipocine today and set a price target of $7.00.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

Chen covers the Healthcare sector, focusing on stocks such as RegenXBio, VolitionRX, and Formycon AG. According to TipRanks, Chen has an average return of -4.3% and a 41.32% success rate on recommended stocks.

Lipocine has an analyst consensus of Moderate Buy, with a price target consensus of $6.88.

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer